Recent Extensive Lung Cancer - Small Cell News

Xgeva Improves Survival Over Zometa in Advanced Lung Cancer (November 28, 2012)

Patients with advanced lung cancer experienced modest improvement in survival when they received bone-targeted therapy with Xgeva® (denosumab) instead of Zometa® (zoledronic acid), according to the results... Continue Reading

Prophylactic Cranial Irradiation May Improve Survival in Small Cell Lung Cancer (June 14, 2011)

Radiation to the brain prior to detectable spread of cancer to the brain improved survival in patients with both early- and late-stage small cell lung cancer. These results were recently presented at the... Continue Reading

Some Patients with Advanced Cancer Continue Screening (October 22, 2010)

A significant proportion of patients with advanced cancers continue to undergo cancer screening, even though screening is unlikely to benefit these patients. These findings were recently reported in the... Continue Reading

Depression May Persist With Metastatic Cancer (May 27, 2010)

A substantial number of patients with metastatic cancer may suffer from depression which tends to persist and grow more severe toward the end of life, according to the results of a study published early... Continue Reading

Most Survivors of Lung and Colorectal Cancer Keep Their Jobs (April 15, 2010)

Among people diagnosed with nonmetastatic lung or colorectal cancer, the majority return to work, according to a study recently published in Journal of Clinical Oncology. Those who do leave the workforce... Continue Reading

November Is National Lung Cancer Awareness Month (November 6, 2009)

As the month of November brings lung cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options,... Continue Reading

Thalidomide Doesn’t Benefit Patients with Small Cell Lung Cancer (July 22, 2009)

Treatment with a combination of thalidomide and chemotherapy did not improve survival among patients with small cell lung cancer, and resulted in a higher risk of blood clots than treatment with chemotherapy... Continue Reading

Higher Chemotherapy Dose Intensity Does Not Improve Survival for Small Cell Lung Cancer (March 8, 2009)

Higher Chemotherapy Dose Intensity Does Not Improve Survival for Small Cell Lung Cancer Increasing the dose intensity of chemotherapy does not appear to improve survival in small cell lung cancer. These... Continue Reading

VePesid®/Platinol® Remains Standard-of-care for Small Cell Lung Cancer (March 8, 2009)

VePesid®/Platinol® Remains Standard-of-care for Small Cell Lung Cancer For patients diagnosed with extensive-stage small-cell lung cancer (SCLC), the standard-of-care remains the chemotherapy combination... Continue Reading

Gemzar® and Paraplatin® Equivalent to Platinol® and VePesid® for SCLC (March 8, 2009)

Gemzar® and Paraplatin® Equivalent to Platinol® and VePesid® for SCLC A combination of Gemzar® (gemcitabine) and Paraplatin® (carboplatin) is as effective as standard Platinol® (cisplatin) and... Continue Reading